Exacerbation Rate
Showing 51 - 75 of >10,000
Pulmonary Disease, Chronic Obstructive Trial (VitalPatch)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- VitalPatch
- (no location specified)
Mar 21, 2022
COPD Exacerbation Acute Trial in Mansoura (Bronchoscopy)
Completed
- COPD Exacerbation Acute
- Bronchoscopy
-
Mansoura, Egyptfaculty of medicine Mansoura university
Sep 14, 2023
COPD, Bronchiolitis Trial in Cardiff (OPEP)
Recruiting
- COPD
- Bronchiolitis
- OPEP
-
Cardiff, Wales, United KingdomMr Carwyn Bridges
Sep 16, 2022
COPD Exacerbation Trial in Istanbul (Teknikel Spirobank Home Type Respiratory Function Tester (Homespirometer), Exercise
Recruiting
- COPD Exacerbation
- Teknikel Spirobank Home Type Respiratory Function Tester (Homespirometer)
- Exercise Programme
-
Istanbul, TurkeySBU Yedikule Chest Diseases and Thoracic Surgery Training and Re
Feb 12, 2023
COPD Exacerbation Trial (Extracorporeal carbon dioxide removal, Conventional Care)
Not yet recruiting
- COPD Exacerbation
- Extracorporeal carbon dioxide removal
- Conventional Care
- (no location specified)
Aug 1, 2022
Tezepelumab PRO Study
Not yet recruiting
- Asthma
- (no location specified)
Jun 20, 2023
Consequences of COVID 19 Pandemic on Childhood Asthma
Recruiting
- Asthma in Children
-
Lille, FranceCHU Lille
May 17, 2022
Sleep Apnea, COPD Exacerbation, Overlap Syndrome Trial (continuous positive airway pressure treatment)
Not yet recruiting
- Sleep Apnea
- +2 more
- continuous positive airway pressure treatment
- (no location specified)
Jul 20, 2023
Reliance on Historical Blood Eosinophil Counts on ICS
Recruiting
- Chronic Obstructive Pulmonary Disease
- Blood Eosinophil counts - comparing historical with stable state
-
North Shields, Tyne And Wear, United KingdomNorth Tyneside General Hospital
Oct 3, 2022
COPD Trial in Sydney (Theophylline, Prednisone, Placebo (for prednisone))
Completed
- Chronic Obstructive Pulmonary Disease
- Theophylline
- +3 more
-
Sydney, New South Wales, AustraliaThe George Institute for Global Health
Aug 10, 2021
Acute Exacerbation of Bronchiectasis in Hong Kong
Recruiting
- Bronchiectasis
-
Hong Kong, Other, Hong KongCharles Wong
Sep 28, 2022
Pulmonary Exacerbations in Non-cystic Fibrosis Bronchiectasis
Not yet recruiting
- Non-cystic Fibrosis Bronchiectasis
- non interventional
-
Cambridge, Cambridgeshire, United KingdomRoyal Papworth Hospital
Nov 21, 2023
COPD, COPD Exacerbation, Pulmonary Rehabilitation Trial in Tainan (Education, Supervision upper limb weight training exercise
Completed
- COPD
- +8 more
- Education
- Supervision upper limb weight training exercise with VR
-
Tainan, TaiwanNational Cheng Kung University Hospital
Jun 9, 2022
Describe Post-authorisation Early Clinical Experience of
Active, not recruiting
- Asthma
- No intervention
-
Chilly-Mazarin, FranceInvestigational Site Number :
Sep 26, 2023
COPD Exacerbation, COPD Exacerbation Acute Trial (Titrated Oxygen, Standard Oxygen)
Not yet recruiting
- COPD Exacerbation
- COPD Exacerbation Acute
- Titrated Oxygen
- Standard Oxygen
- (no location specified)
Feb 2, 2023
Acute Exacerbation of COPD Trial in Konya (Treatment group, Chair-Based Exercise Training, Control group, Breathing exercise)
Recruiting
- Acute Exacerbation of COPD
- Treatment group, Chair-Based Exercise Training
- Control group, Breathing exercise
-
Konya, TurkeyNecmettin Erbakan University Nezahat Keleşoğlu Faculty of Health
Sep 29, 2022
Bronchiectasis Trial in Kuala Lumpur (Nebulized 5% Hypertonic saline, Placebo)
Recruiting
- Bronchiectasis
- Nebulized 5% Hypertonic saline
- Placebo
-
Kuala Lumpur, Lembah Pantai, MalaysiaUniversity Malaya Medical Centre
May 16, 2022
Asthma Trial in Worldwide (Tezepelumab)
Recruiting
- Asthma
- Tezepelumab
-
Newport Beach, California
- +102 more
Jan 11, 2023
Acute Exacerbation of Bronchiectasis Trial in Shanghai (anti-infective therapy sitafloxacin, anti-infective therapy
Active, not recruiting
- Acute Exacerbation of Bronchiectasis
- anti-infective therapy sitafloxacin
- anti-infective therapy levofloxacin
-
Shanghai, Shanghai, ChinaShanghai pulmonary hospital
Apr 5, 2022
COPD (COPD) Trial in Israel (SenseGuard Investigational Device)
Recruiting
- Chronic Obstructive Pulmonary Disease (COPD)
- SenseGuard Investigational Device
-
Ashkelon, Israel
- +3 more
Mar 14, 2022
Acute Exacerbation of COPD Trial in China (High-intensity NPPV, Conventional-intensity NPPV)
Completed
- Acute Exacerbation of Chronic Obstructive Pulmonary Disease
- High-intensity NPPV
- Conventional-intensity NPPV
-
Baoji, China
- +26 more
May 14, 2022
COPD Trial in Beijing (Staphylococcus and Neisseria Tablets)
Not yet recruiting
- Chronic Obstructive Pulmonary Disease
- Staphylococcus and Neisseria Tablets
-
Beijing, Beijing, ChinaPeking University Third Hospital
Aug 3, 2023
Real-world, 52-week Prospective Study to Capture Reasons for
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive (COPD)
- Budesonide Glycopyrronium bromide Formoterol fumarate pressurized Metered Dose Inhaler
- (no location specified)
Jun 13, 2023
COPD Trial in Beijing (Digital Intervention)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Digital Intervention
-
Beijing, Beijing, ChinaChina-Japan Friendship hospital
Dec 19, 2022